ADAP 0.99 (-3.88%)
US00653A1079BiotechnologyBiotechnology

Adaptimmune Therapeutics (ADAP) Competitor Comparison

We are evaluating the key criteria listed to compare Adaptimmune Therapeutics (ADAP) against its competitors in the Biotechnology industry.

Gross Profits - ADAP ranking 245 / 285

These are the competitors of Adaptimmune Therapeutics in the industry Biotechnology ranked by gross profits
1. Moderna MRNA
10.55B
2. ImmuCell ICCC
7.65B
3. Regeneron Pharmaceuticals REGN
7.02B
4. Vertex Pharmaceuticals VRTX
5.32B
5. Jazz Pharmaceuticals JAZZ
3.39B
6. United Therapeutics UTHR
1.78B
7. Biomarin Pharmaceutical BMRN
1.61B
8. Incyte INCY
1.59B
9. Exelixis EXEL
1.55B
10. Royalty Pharma RPRX
1.33B
11. Vir Biotechnology VIR
1.03B
12. Neurocrine Biosciences NBIX
1B
13. Alkermes ALKS
893.69M
14. Alnylam Pharmaceuticals ALNY
868.6M
15. Bio-Techne TECH
770.22M
16. Maravai LifeSciences Holdings MRVI
714.04M
17. Halozyme Therapeutics HALO
454.21M
18. Dynavax Technologies DVAX
448.22M
19. Corcept Therapeutics CORT
396.47M
20. Harmony Biosciences Holdings HRMY
354.37M
21. AbCellera Biologics ABCL
311.11M
22. Amicus Therapeutics FOLD
290.63M
23. Intercept Pharmaceuticals ICPT
284.73M
24. Innoviva INVA
276.11M
25. Ginkgo Bioworks Holdings DNA
273.49M
26. ITeos Therapeutics ITOS
267.63M
27. Arrowhead Pharmaceuticals ARWR
240.74M
28. Vanda Pharmaceuticals VNDA
230.1M
29. Seagen SGEN
207.99M
30. Certara CERT
203.07M
31. Veracyte VCYT
194.95M
32. Global Blood Therapeutics GBT
191.43M
33. Insmed INSM
190.23M
34. Pharming Group PHAR
188.06M
35. Blueprint Medicines BPMC
177.28M
36. Kiniksa Pharmaceuticals KNSA
173.21M
37. Puma Biotechnology PBYI
172.94M
38. Catalyst Pharmaceuticals CPRX
160.02M
39. Karyopharm Therapeutics KPTI
151.86M
40. ACADIA Pharmaceuticals ACAD
145.49M
41. Akebia Therapeutics AKBA
140.04M
42. Arvinas ARVN
131.4M
43. Vericel VCEL
109.79M
44. Ligand Pharmaceuticals LGND
107.34M
45. Paratek Pharmaceuticals PRTK
99.39M
46. Anika Therapeutics ANIK
96.78M
47. Intra-Cellular Therapies ITCI
95.16M
48. Cerus CERS
87.09M
49. Enanta Pharmaceuticals ENTA
86.16M
50. Lyell Immunopharma LYEL
84.68M
51. Aurinia Pharmaceuticals AUPH
83.38M
52. Acorda Therapeutics ACOR
82.43M
53. SIGA Technologies SIGA
77.82M
54. BridgeBio Pharma BBIO
74.21M
55. Myovant Sciences MYOV
72.02M
56. Apellis Pharmaceuticals APLS
69.79M
57. Aytu BioPharma AYTU
66.63M
58. Mirum Pharmaceuticals MIRM
64.69M
59. Arcturus Therapeutics Holdings ARCT
62.95M
60. Y-mAbs Therapeutics YMAB
57.7M
61. UroGen Pharma URGN
56.7M
62. Berkeley Lights BLI
53.78M
63. Rigel Pharmaceuticals RIGL
53.72M
64. CytomX Therapeutics CTMX
53.16M
65. CTI BioPharma CTIC
50.43M
66. G1 Therapeutics GTHX
47.55M
67. Axsome Therapeutics AXSM
45.94M
68. ChromaDex CDXC
42.8M
69. MannKind MNKD
42.27M
70. Albireo Pharma ALBO
39.22M
71. ADMA Biologics ADMA
35.27M
72. ADC Therapeutics ADCT
35.1M
73. Avid Bioservices CDMO
31.48M
74. Turning Point Therapeutics TPTX
30.83M
75. Aquestive Therapeutics AQST
28.29M
76. Protalix BioTherapeutics PBDA.F
28.05M
77. VectivBio Holding VECT
27.34M
78. Jounce Therapeutics JNCE
27.2M
79. EyePoint Pharmaceuticals EYPT
26.95M
80. KemPharm KMPH
26.59M
81. Protagonist Therapeutics PTGX
26.58M
82. Precision BioSciences DTIL
25.1M
83. Adicet Bio ACET
24.99M
84. Champions Oncology CSBR
24.34M
85. Cellectis CLLS
23.95M
86. Rhythm Pharmaceuticals RYTM
21.51M
87. F-star Therapeutics FSTX
21.17M
88. Precigen PGEN
20.57M
89. Codexis CDXS
20.46M
90. MeiraGTx Holdings MGTX
15.92M
91. Equillium EQ
15.76M
92. Ardelyx ARDX
15.54M
93. Repare Therapeutics RPTX
15.11M
94. Eton Pharmaceuticals ETON
14.32M
95. MediWound MDWD
13.17M
96. Liquidia LQDA
13.08M
97. Agios Pharmaceuticals AGIO
12.54M
98. Stoke Therapeutics STOK
12.41M
99. Eiger BioPharmaceuticals EIGR
11.65M
100. BioCryst Pharmaceuticals BCRX
10.94M
101. Karuna Therapeutics KRTX
10.64M
102. Pliant Therapeutics PLRX
9.69M
103. Spectrum Pharmaceuticals SPPI
8.32M
104. Verrica Pharmaceuticals VRCA
8.31M
105. Ambrx Biopharma AMAM
7.4M
106. Seer SEER
7.09M
107. BioStem Technologies BSEM
5.99M
108. XOMA XOMA
5.87M
109. Organicell Regenerative Medicine OCEL
5.74M
110. Comp SBS
5.32M
111. Milestone Pharmaceuticals MIST
5M
112. XBiotech XBIT
3.36M
113. Aptevo Therapeutics APVO
3.11M
114. Arcutis Biotherapeutics ARQT
2.93M
115. Oramed Pharmaceuticals ORMP
2.7M
116. PTC Therapeutics PTCT
2.63M
117. Verastem VSTM
2.6M
118. TG Therapeutics TGTX
2.52M
119. Taysha Gene Therapies TSHA
2.5M
120. Capricor Therapeutics CAPR
1.75M
121. Bolt Biotherapeutics BOLT
1.62M
122. RAPT Therapeutics RAPT
1.53M
123. Lumos Pharma LUMO
1.52M
124. Ovid Therapeutics OVID
1.5M
125. Fennec Pharmaceuticals FENC
1.45M
126. Relay Therapeutics RLAY
1.38M
127. Kala Pharmaceuticals KALA
1.33M
128. Cue Biopharma CUE
1.25M
129. Cyclo Therapeutics CYTH
1.23M
130. Synlogic SYBX
1.18M
131. Clearside Biomedical CLSD
1.12M
132. IGM Biosciences IGMS
1.07M
133. SciSparc SPRC
1.03M
134. SELLAS Life Sciences Group SLS
900K
135. Dyadic DYAI
807.11K
136. Nutriband NTRB
750.41K
137. Lipocine LPCN
500K
138. VYNE Therapeutics VYNE
477K
139. INmune Bio INMB
374K
140. BioXcel Therapeutics BTAI
355K
141. Rafael Holdings RFL
279K
142. Allogene Therapeutics ALLO
243K
143. ImmunityBio IBRX
240K
144. Regen BioPharma RGBPP
235.52K
145. ATAI Life Sciences ATAI
233K
146. Opthea OPT
218.45K
147. Polydex Pharmaceuticals POLXF
211.62K
148. BioRestorative Therapies BRTX
119.8K
149. Verona Pharma VRNA
112K
150. GlycoMimetics GLYC
75K
151. Benitec Biopharma BNTC
75K
152. Cormedix CRMD
61.67K
153. Entera Bio ENTX
33K
154. BELLUS Health BLU
16K
155. Arch Therapeutics ARTH
-35.84K
156. VistaGen Therapeutics VTGN
-227.3K
157. Aeglea BioTherapeutics AGLE
-262K
158. Celularity CELU
-1.69M
159. Ocular Therapeutix OCUL
-6.51M
160. Gain Therapeutics GANX
-7.66M
161. Idera Pharmaceuticals IDRA
-9.25M
162. Plus Therapeutics PSTV
-9.47M
163. vTv Therapeutics VTVT
-9.93M
164. Liminal Biosciences LMNL
-10.89M
165. Theravance Biopharma TBPH
-12.05M
166. SAB Biotherapeutics SABS
-12.53M
167. Adaptive Biotechnologies ADPT
-13.66M
168. Vaccinex VCNX
-13.7M
169. Angion Biomedica ANGN
-15.8M
170. ProMIS Neurosciences PMN
-16.09M
171. Corbus Pharmaceuticals Holdings CRBP
-16.14M
172. Tarsus Pharmaceuticals TARS
-17.76M
173. Aadi Bioscience AADI
-18.78M
174. eFFECTOR Therapeutics EFTR
-19.76M
175. Voyager Therapeutics VYGR
-19.86M
176. Revance Therapeutics RVNC
-20.39M
177. Candel Therapeutics CADL
-20.66M
178. Poseida Therapeutics PSTX
-22.41M
179. Sigilon Therapeutics SGTX
-24.69M
180. Cardiff Oncology CRDF
-26.72M
181. Morphic Holding MORF
-31.25M
182. Travere Therapeutics TVTX
-31.35M
183. Oncternal Therapeutics ONCT
-31.49M
184. Acumen Pharmaceuticals ABOS
-32.36M
185. aTyr Pharma LIFE
-32.42M
186. Lyra Therapeutics LYRA
-34.23M
187. Xencor XNCR
-34.98M
188. Surface Oncology SURF
-37M
189. Werewolf Therapeutics HOWL
-37.36M
190. IDEAYA Biosciences IDYA
-38.61M
191. Alpine Immune Sciences ALPN
-40.18M
192. CymaBay Therapeutics CBAY
-41.64M
193. Outlook Therapeutics OTLK
-42.33M
194. Janux Therapeutics JANX
-44.83M
195. Arbutus Biopharma ABUS
-45.39M
196. TScan Therapeutics TCRX
-46.28M
197. Mesoblast MESO
-47.42M
198. Design Therapeutics DSGN
-48.61M
199. Ikena Oncology IKNA
-48.7M
200. Harpoon Therapeutics HARP
-49.48M
201. Ocugen OCGN
-49.76M
202. ChemoCentryx CCXI
-51.07M
203. Lexicon Pharmaceuticals LXRX
-52.68M
204. NextCure NXTC
-54.2M
205. Concert Pharmaceuticals CNCE
-54.98M
206. Marinus Pharmaceuticals MRNS
-55.94M
207. DICE Therapeutics DICE
-56.08M
208. Finch Therapeutics Group FNCH
-57.03M
209. Fusion Pharmaceuticals FUSN
-57.43M
210. Coherus BioSciences CHRS
-58.4M
211. Aclaris Therapeutics ACRS
-60.02M
212. Macrogenics MGNX
-62.47M
213. Deciphera Pharmaceuticals DCPH
-62.56M
214. Provention Bio PRVB
-63.42M
215. Bic BCYC
-67.15M
216. Cassava Sciences SAVA
-68.03M
217. Caribou Biosciences CRBU
-68.38M
218. Esperion Therapeutics ESPR
-70.42M
219. Fulcrum Therapeutics FULC
-70.44M
220. Altimmune ALT
-70.52M
221. Omega Therapeutics OMGA
-74.02M
222. Amylyx Pharmaceuticals AMLX
-74.21M
223. Alector ALEC
-76.8M
224. 4D Molecular Therapeutics FDMT
-77.12M
225. Sarepta Therapeutics SRPT
-78.07M
226. AnaptysBio ANAB
-78.51M
227. BioAtla BCAB
-79.35M
228. Celldex Therapeutics CLDX
-79.9M
229. KalVista Pharmaceuticals KALV
-80.28M
230. Vaxart VXRT
-80.95M
231. Tango Therapeutics TNGX
-81.05M
232. Prothena PRTA
-81.66M
233. Atea Pharmaceuticals AVIR
-81.94M
234. Shattuck Labs STTK
-82.25M
235. Foghorn Therapeutics FHTX
-86.39M
236. C4 Therapeutics CCCC
-86.75M
237. Keros Therapeutics KROS
-87.27M
238. uniQure QURE
-87.37M
239. Scholar Rock Holding SRRK
-89.85M
240. Gritstone Bio GRTS
-91.46M
241. Geron GERN
-93.67M
242. Homology Medicines FIXX
-95.14M
243. Xenon Pharmaceuticals XENE
-96.33M
244. Viridian Therapeutics VRDN
-99.12M
245. Adaptimmune Therapeutics ADAP
-100.58M
246. Immunogen IMGN
-104.76M
247. Prometheus Biosciences RXDX
-106.04M
248. Merus MRUS
-107.84M
249. Inhibrx INBX
-107.99M
250. IVERIC bio ISEE
-117.01M
251. Kymera Therapeutics KYMR
-117.42M
252. Crinetics Pharmaceuticals CRNX
-125.49M
253. NGM Biopharmaceuticals NGM
-125.73M
254. Verve Therapeutics VERV
-128.15M
255. Autolus Therapeutics AUTL
-130.86M
256. Chinook Therapeutics KDNY
-135.08M
257. Avidity Biosciences RNA
-141.18M
258. Zai Lab ZLAB
-145.39M
259. Nurix Therapeutics NRIX
-145.87M
260. Cytokinetics CYTK
-146.23M
261. Mersana Therapeutics MRSN
-146.8M
262. Editas Medicine EDIT
-155.25M
263. Novavax NVAX
-156.05M
264. FibroGen FGEN
-159.21M
265. Recursion Pharmaceuticals RXRX
-164.13M
266. Reata Pharmaceuticals RETA
-167.63M
267. Arcus Biosciences RCUS
-176M
268. Inovio Pharmaceuticals INO
-177.39M
269. Regenxbio RGNX
-184.27M
270. Revolution Medicines RVMD
-217.69M
271. Fate Therapeutics FATE
-224.15M
272. bluebird bio BLUE
-247.24M
273. Denali Therapeutics DNLI
-250.27M
274. Beam Therapeutics BEAM
-250.67M
275. argenx ARGX
-251.79M
276. Ionis Pharmaceuticals IONS
-257.87M
277. HUTCHMED (China) HCM
-271.59M
278. Legend Biotech LEGN
-284.01M
279. Sage Therapeutics SAGE
-319.29M
280. Intellia Therapeutics NTLA
-367.86M
281. Ultragenyx Pharmaceutical RARE
-370.78M
282. Roivant Sciences ROIV
-477.06M
283. BeiGene BGNE
-511.06M
284. Mirati Therapeutics MRTX
-519.79M
285. CRISPR Therapeutics CRSP
-570.7M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.